Mercè Planas1, Julia Álvarez-Hernández2, Miguel León-Sanz3, Sebastián Celaya-Pérez4, Krysmarú Araujo5, Abelardo García de Lorenzo6. 1. Escola de Ciències de la Salut, Universitat de Vic, Avenida Mare de Deu de Montserrat, número 10, 6 piso, puerta 3, 08024, Barcelona, Spain. mplanasvila@gmail.com. 2. Hospital Universitario Príncipe de Asturias, Madrid, Spain. 3. Clinical Nutrition Unit, Hospital Universitario 12 de Octubre, Madrid, Spain. 4. Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. 5. Medical Affairs, Nestlé HealthScience, Barcelona, Spain. 6. Hospital Universitario La Paz, Madrid, Spain.
Abstract
PURPOSE: In oncology patients, hospital malnutrition is associated with a greater risk of morbidity and mortality. The objective of this study was to determine the prevalence of nutritional risk and the clinical and economic consequences of hospital malnutrition in oncology patients hospitalised in Spanish centres. METHODS: This was an observational, cross-sectional, multicentre study. The prevalence of nutritional risk was determined using the Nutrition Risk Screening(®)-2002 (NRS(®)-2002). RESULTS: Four hundred one oncology patients were included; 33.9% (136/401) were at nutritional risk (NRS(®)-2002 ≥ 3) at admission and 36.4% (135/371) at discharge. On average, patients at nutritional risk were more elderly and had lower weights, body mass indices and arm and calf circumferences, as well as lower serum albumin levels than patients not at risk. Mean duration of hospitalisation and healthcare costs were greater in patients at nutritional risk at discharge (12.1 days; 95% confidence interval (CI) 10.83-13.39) than in well-nourished patients (8.6 days; 95% CI 7.86-9.40). Only a third of the patients at risk of malnutrition at discharge had received any kind of nutritional support. CONCLUSIONS: This study shows that hospital malnutrition is a prevalent and undertreated condition in oncology patients that is associated with longer hospital stays and increased healthcare costs.
PURPOSE: In oncology patients, hospital malnutrition is associated with a greater risk of morbidity and mortality. The objective of this study was to determine the prevalence of nutritional risk and the clinical and economic consequences of hospital malnutrition in oncology patients hospitalised in Spanish centres. METHODS: This was an observational, cross-sectional, multicentre study. The prevalence of nutritional risk was determined using the Nutrition Risk Screening(®)-2002 (NRS(®)-2002). RESULTS: Four hundred one oncology patients were included; 33.9% (136/401) were at nutritional risk (NRS(®)-2002 ≥ 3) at admission and 36.4% (135/371) at discharge. On average, patients at nutritional risk were more elderly and had lower weights, body mass indices and arm and calf circumferences, as well as lower serum albumin levels than patients not at risk. Mean duration of hospitalisation and healthcare costs were greater in patients at nutritional risk at discharge (12.1 days; 95% confidence interval (CI) 10.83-13.39) than in well-nourished patients (8.6 days; 95% CI 7.86-9.40). Only a third of the patients at risk of malnutrition at discharge had received any kind of nutritional support. CONCLUSIONS: This study shows that hospital malnutrition is a prevalent and undertreated condition in oncology patients that is associated with longer hospital stays and increased healthcare costs.
Authors: Digant Gupta; Christopher G Lis; Joel Granick; James F Grutsch; Pankaj G Vashi; Carolyn A Lammersfeld Journal: J Clin Epidemiol Date: 2006-04-19 Impact factor: 6.437
Authors: J Arends; G Bodoky; F Bozzetti; K Fearon; M Muscaritoli; G Selga; M A E van Bokhorst-de van der Schueren; M von Meyenfeldt; G Zürcher; R Fietkau; E Aulbert; B Frick; M Holm; M Kneba; H J Mestrom; A Zander Journal: Clin Nutr Date: 2006-05-12 Impact factor: 7.324
Authors: W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey Journal: Am J Med Date: 1980-10 Impact factor: 4.965
Authors: Elena Álvaro Sanz; Jimena Abilés; Margarita Garrido Siles; Elísabeth Pérez Ruíz; Julia Alcaide García; Antonio Rueda Domínguez Journal: Support Care Cancer Date: 2020-05-18 Impact factor: 3.603
Authors: Patricia G Wolf; Joanna Manero; Kirsten Berding Harold; Morgan Chojnacki; Jennifer Kaczmarek; Carli Liguori; Anna Arthur Journal: Support Care Cancer Date: 2019-05-23 Impact factor: 3.603
Authors: Cliona M Lorton; O Griffin; K Higgins; F Roulston; G Stewart; N Gough; E Barnes; A Aktas; T D Walsh Journal: Support Care Cancer Date: 2019-09-04 Impact factor: 3.603
Authors: J A Virizuela; M Camblor-Álvarez; L M Luengo-Pérez; E Grande; J Álvarez-Hernández; M J Sendrós-Madroño; P Jiménez-Fonseca; M Cervera-Peris; M J Ocón-Bretón Journal: Clin Transl Oncol Date: 2017-10-17 Impact factor: 3.405
Authors: Hong-Juan Zhou; Li-Jin Deng; Tao Wang; Jin-Xiu Chen; Su-Zhen Jiang; Liu Yang; Fang Liu; Mei-Hua Weng; Jing-Wen Hu; Jing-Yu Tan Journal: Support Care Cancer Date: 2021-02-27 Impact factor: 3.603